Rheumatoid factor

Source: Wikipedia, the free encyclopedia.

Rheumatoid factor (RF) is the

IgG and different RFs can recognize different parts of the IgG-Fc.[1] RF and IgG join to form immune complexes that contribute to the disease process such as chronic inflammation and joint destruction at the synovium and cartilage.[2]

Rheumatoid factor can also be a

polyclonal
IgG) or type 3 (polyclonal IgM to polyclonal IgG) cryoglobulin.

Although predominantly encountered as IgM, rheumatoid factor can be of any

immunoglobulins; i.e., IgA, IgG, IgM,[3] IgE,[4] IgD.[5]

Testing

RF is tested by collecting blood in a plain tube (5 mL is often enough). The serum is tested for the presence of RF. There are different methods available, which include

symptoms, it can play a role in both diagnosis and disease prognosis. It is part of the usual disease criteria of rheumatoid arthritis.[6]

The presence of rheumatoid factor in serum can also indicate the occurrence of suspected autoimmune activity unrelated to rheumatoid arthritis, such as that associated with tissue or organ rejection. In such instances, RF may serve as one of several serological markers for autoimmunity.[7] The sensitivity of RF for established rheumatoid arthritis is only 60 to 70 percente with a specificity of 78 percent.[8]

Rheumatoid factor is part of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis. RF positivity combines well with

anti-CCP and/or 14-3-3η (YWHAH) to inform diagnosis.[9] RF positivity at baseline has also been described as a good prognostic marker for future radiographic damage.[10]

Interpretation

High levels of rheumatoid factor (in general, above 20 

Parvovirus
infection and in 5–10% of healthy persons, especially the elderly.

There is an association between rheumatoid factor and more persistently active synovitis, more joint damage, greater eventual disability and arthritis.[12][13]

Other than in rheumatoid arthritis, rheumatoid factor may also be elevated in other conditions, including:

History

The test was first described by Norwegian Dr Erik Waaler in 1940 and redescribed by Dr Harry M. Rose and colleagues in 1948. Redescription is said to be due to the uncertainties due to World War II. It is still referred to as the Waaler–Rose test.[19][20]

References

  1. PMID 26246004
    .
  2. ^ Edkins A, Cushley W (2012). "The Jekyll and Hyde nature of antibodies". Biological Sciences Review. 25 (2): 4.
  3. PMID 3775335
    .
  4. .
  5. .
  6. ^ Rheumatoid Arthritis~workup at eMedicine
  7. S2CID 6941129
    .
  8. .
  9. ^ Zhang Y, Liang Y, Feng L, Cui L. Diagnostic performance of 14-3-3η and anti-carbamylated protein antibodies in Rheumatoid Arthritis in Han population of Northern China. Clin Chim Acta. 2020 Mar;502:102-110. doi: 10.1016/j.cca.2019.12.011. Epub 2019 Dec 17. PMID: 31862264.
  10. ^ Bukhari M, Lunt M, Harrison BJ, Scott DG, Symmons DP, Silman AJ. Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis: results from the Norfolk Arthritis Register Study, a large inception cohort. Arthritis Rheum. 2002 Apr;46(4):906-12. doi: 10.1002/art.10167. PMID: 11953966.
  11. ^ Rheumatoid Factor - Patient UK
  12. ^ [1] [full citation needed]
  13. ^ The Arthritis Association, Report by MHC 19.2
  14. ^ a b c d "Rheumatoid factor - Mayo Clinic". Mayo Clinic.
  15. ^ a b c d e f g Johnson, Jon (21 July 2021). "Rheumatoid factor: Ranges, tests, and treatment". Medical News Today. Retrieved 13 May 2022.
  16. PMID 28149646
    .
  17. .
  18. .
  19. .
  20. .

External links